Before deciding the "societal value" of the new medicine, its performance in clinical trials, possible side effects, and accessibility must be closely examined.
Lecanemab is the first drug proven to slow the progression of Alzheimer's. Its manufacturer Eisai calculated its societal value to determine a suitable price.
It’s not just money that is lacking. Successful development of medical therapeutics in Japan ー including vaccines ー takes transparency and ethical policies.
Japan’s Takeda Pharmaceutical Company Ltd. is speeding up the process of collecting the blood of patients who have recovered from COVID-19 in various parts of...